Calisa Files Amendment No. 4 to Goodvision Merger S-4 with Updated Financials and $9M Financing Details
ALIS is trading near its 52-week low of $9.85 (3.7% above the low).
Summary
Amendment No. 4 to the Goodvision AI merger S-4 updates pro forma financials, discloses $9M in secured financing, and reveals material weaknesses in Goodvision's internal controls.
Key Events · M&A and Partnerships · ALIS
-
Amendment No. 4 Filed
Calisa filed Amendment No. 4 to its S-4 registration statement on August 31, 2026, updating the Goodvision AI merger proxy statement/prospectus with financial information as of June 30, 2026.
-
Updated Financial Projections
Updated Management Projections show Goodvision revenue growing from $7.7M in FY2025 to $38.9M projected for FY2026, $176.6M for FY2027, and $418.6M for FY2028, with net income turning positive in FY2026.
-
$9M Financing Secured
The filing discloses $9.0M in secured equity financing: $1.0M from April 2026 subscription (100,000 shares), $8.0M from July 2026 PIPE (800,000 shares), plus $2.83M debt conversion (283,000 shares) and a $1.0M convertible note.
-
Material Weaknesses Disclosed
Goodvision has identified material weaknesses in internal control over financial reporting, including ineffective control environment, lack of segregation of duties, and insufficient qualified accounting resources.
Analysis · ALIS · Technology
This fourth amendment to the S-4 registration statement provides the most current financial picture of the pending Goodvision AI merger. It includes updated pro forma financials as of June 30, 2026, revised management projections showing revenue growth from $7.7M in FY2025 to a projected $38.9M in FY2026, and details of $9.0M in secured financing. The filing also discloses material weaknesses in Goodvision's internal controls and a dual-class share structure that will give CEO Yi Wang approximately 76.84% voting control post-merger. For SPAC shareholders, the key decision is whether to redeem at approximately $10.25 per share or hold shares in a company with significant dilution, concentrated control, and a going-concern risk.
How filings like this one have moved
In the 30 days to Sep 10, 2026, 35.7% of the 1872 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.01%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, ALIS was trading at $10.21 on NASDAQ in the Technology sector, with a market capitalization of approximately $86M. The 52-week trading range was $9.85 to $10.25. This filing was assessed with neutral market sentiment and an importance score of 8 out of 10.